Cellis Partners with University Hospital Zurich for Cutting-Edge Glioblastoma Treatment Research with MDC Technology

Cellis signed an agreement with University Hospital Zurich (Switzerland) for pre-clinical development of MDC technology in glioblastoma treatment. In this project Cellis will collaborate with Dr. Tobias Weiss and Prof. Michael Weller from UHZ Neurology Clinic, one of the most recognized glioblastoma centers.